Michael Eric Smith - 17 Feb 2022 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Reporting relationship: Chief Operating Officer
Issuer ticker: DNMRQ
Reported as of: 17 Feb 2022
Net transaction value: -$7,700
SEC form: 4
Accepted by SEC: 22 Feb 2022, 15:06:01 UTC
Prior SEC filing: 20 Jan 2022
Next SEC filing: 03 Jan 2023
Source filing: View source filing
Reporting owner signature: /s/ Michael Smith

Key filing fact

Michael Eric Smith filed Form 4 for Danimer Scientific, Inc. (DNMRQ) on 22 Feb 2022.

Key facts

This page summarizes Michael Eric Smith's Form 4 filing for Danimer Scientific, Inc. (DNMRQ).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Feb 2022, 15:06.

Change

Previous filing in this sequence was filed on 20 Jan 2022.
Current net transaction value: -$7,700.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DNMR transaction

Class A Common Stock ("Common Stock")

Options Exercise

Transaction value: $32,800
Shares: +10,000
Change %: +2.9%
Price: $3.28
Shares after: 358,744
Date: 17 Feb 2022
Ownership: Direct
Footnotes: F1

DNMR transaction

Common Stock

Sale

Transaction value: $40,500
Shares: -10,000
Change %: -2.8%
Price: $4.05
Shares after: 348,744
Date: 17 Feb 2022
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DNMR transaction Derivative

Stock Option (right to purchase)

Options Exercise

Transaction value: $0
Shares: -10,000
Change %: -1.6%
Price: $0.000000
Shares after: 608,909
Date: 17 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $3.28
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Includes 348,744 restricted shares of the Common Stock granted under a previously disclosed restricted stock award.

Footnote F2

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Smith on June 25, 2021. The Reporting Person exercised no discretion with respect to the sale. Proceeds from the sale were used to pay the exercise price of stock options, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes.

Footnote F3

The options are fully vested and currently exercisable.